Dr. Virginia Kaklamani joins Healthcare Unfiltered EXPRESS to discuss the recent FDA-approved indications for T-DXd in breast cancer, and what this means for treating patients with the disease. A critical episode ahead of the annual ASCO meeting. Check it out, subscribe, rate, review, and join the conversation.

Dr. Rani Bansal of Duke University joins the show to share her insights on the latest ESMO Breast meeting that concluded in Berlin. Dr. Rani shares data on the top 5 abstracts that may change or inform practice.

Check it out, share, subscribe, and join the conversation.

Dr. Emily Landon of the University of Chicago joins the show to explain everything you must know about the Hantavirus - should we be concerned? What to do? What not to do? Is this another COVID?
Get the facts right here, and please share, subscribe, and join the conversation.

Dr. Deva Mahalingam shares on Healthcare Unfiltered EXPRESS a new paper published in Nature Medicine on a regimen showing significant promise in pancreatic cancer. You want to listen to this podcast and check out the paper. https://www.nature.com/articles/s41591-026-04327-4

Share, subscribe, and join the conversation.

Dr. Matt Davids of the Dana Farber Cancer Institute joins Healthcare Unfiltered EXPRESS to share his data-solidified insights on navigating the treatment of relapsed/refractory (R/R) CLL, considering the welcome advances the field has witnessed in treating front-line disease. Check it out, subscribe, rate, and join the conversation.

Dr. Vincent Rajkumar of the Mayo Clinic joins the Healthcare Unfiltered EXPRESS to highlight a major study recently published in the NEJM concerning patients with R/R multiple myeloma. This study is arguably changing the standard of care for relapsed disease. We discussed the study, its rationale, its implications, and limitations.

Here is a link to the actual publication: https://www.nejm.org/doi/full/10.1056/NEJMoa2514663

Please subscribe, rate, share, review, and join the conversation.

Dr. Andrea Apolo from the NCI and the co-Chair of the ASCO GU 2026 scientific program joined the Healthcare Unfiltered EXPRESS to share what she viewed as potentially practice-changing data in bladder cancer. She discussed what she viewed as the top 4 abstracts to be aware of.

Stay up to date on all oncology meetings by subscribing to Healthcare Unfiltered EXPRESS; share with colleagues, and join the conversation.

Dr. Shilpa Gupta of Cleveland Clinic joins Healthcare Unfiltered EXPRESS to share three major abstracts from the ASCO-GU-2026 meeting that could change clinical practice in kidney and prostate cancers. Dr. Gupta brings this data home by explaining their impact on real-world practices. Check these out, subscribe, review, and join the conversation.